For those with chronic heart failure (CHF), about 17-45% globally die within one year of hospital admission. Mesoblast is conducting a Phase 3 clinical trial of a regenerative therapy that may potentially help those living with CHF
For those with chronic heart failure (CHF), about 17-45%...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.35 |
Change
0.020(1.50%) |
Mkt cap ! $1.541B | |||
| Open | High | Low | Value | Volume |
| $1.35 | $1.40 | $1.34 | $3.562M | 2.615M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15000 | $1.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.36 | 17969 | 2 |
View Market Depth
| Last trade - 16.10pm 07/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |